Aprotinin in aortic surgery requiring profound hypothermia and circulatory arrest.

[1]  M. Oz,et al.  Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. , 1995, The Annals of thoracic surgery.

[2]  G. Westney,et al.  Aprotinin reduces blood loss in lung transplant recipients. , 1995, The Annals of thoracic surgery.

[3]  R. Bonser,et al.  Retrograde cerebral perfusion: clinical experience in emergency and elective aortic operations. , 1995, The Annals of thoracic surgery.

[4]  G. Guiraudon,et al.  Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. , 1994, The Journal of thoracic and cardiovascular surgery.

[5]  J. Dunning,et al.  Aprotinin and bleeding in profoundly hypothermic perfusion. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  T. Sundt,et al.  Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. , 1993, The Annals of thoracic surgery.

[7]  S. Westaby.  Aprotinin in perspective. , 1993, The Annals of thoracic surgery.

[8]  M. Jochum,et al.  Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. , 1993, The Journal of thoracic and cardiovascular surgery.

[9]  W. van Oeveren,et al.  Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. , 1991, The Annals of thoracic surgery.

[10]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[11]  M. Elliott,et al.  Aprotinin in paediatric cardiac surgery , 1990 .

[12]  R. Sapsford,et al.  Aprotinin in aspirin-pretreated patients , 1990 .

[13]  J. Griffin,et al.  Aprotinin (trasylol) is a competitive inhibitor of activated protein C. , 1989, Thrombosis research.

[14]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[15]  L. Edmunds,et al.  Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.

[16]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.

[17]  W. van Oeveren,et al.  Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.

[18]  R. Mohr,et al.  Effect of cardiac operation on platelets. , 1986, The Journal of thoracic and cardiovascular surgery.

[19]  R. Colman,et al.  Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. , 1985, The Journal of laboratory and clinical medicine.

[20]  A. Krian.  Incidence, Prevention, and Treatment of Acute Renal Failure following Cardiopulmonary Bypass , 1976, International Anesthesiology Clinics.